SC
URGN icon

Steven Cohen’s UroGen Pharma URGN Stock Holding History

Steven Cohen’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.1M Buy
+1,525,549
New +$41.3M 0.06% 391
2025
Q3 		– Sell
-168,779
Closed -$2.31M – 2702
2025
Q2 		$2.31M Sell
168,779
-67,227
-28% -$645K ﹤0.01% 1241
2025
Q1 		$2.61M Sell
236,006
-81,108
-26% -$865K 0.01% 1159
2024
Q4 		$3.38M Sell
317,114
-1,189,532
-79% -$14.2M 0.01% 1069
2024
Q3 		$19.1M Sell
1,506,646
-942,631
-38% -$14M 0.05% 432
2024
Q2 		$41.1M Buy
2,449,277
+1,337,257
+120% +$19M 0.11% 248
2024
Q1 		$16.7M Buy
1,112,020
+986,020
+783% +$16.1M 0.04% 521
2023
Q4 		$1.89M Sell
126,000
-81,733
-39% -$1.06M ﹤0.01% 1229
2023
Q3 		$2.91M Buy
+207,733
New +$3.33M 0.01% 1040
2020
Q1 		– Sell
-222,024
Closed -$7.41M – 1095
2019
Q4 		$7.41M Buy
222,024
+164,222
+284% +$4.48M 0.04% 436
2019
Q3 		$1.38M Buy
57,802
+290
+0.5% +$9.48K 0.01% 644
2019
Q2 		$2.07M Sell
57,512
-206,087
-78% -$7.6M 0.01% 647
2019
Q1 		$9.74M Buy
263,599
+198,599
+306% +$8.33M 0.04% 412
2018
Q4 		$2.8M Buy
65,000
+12,954
+25% +$582K 0.01% 668
2018
Q3 		$2.46M Buy
+52,046
New +$2.42M 0.01% 733

Other funds holding URGN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Steven Cohen's URGN Position: Q2 2026 in Review

Steven Cohen opened a new position in UroGen Pharma (URGN) in Q2 2026: 1,525,549 shares worth $56.1M. The stake represents 0.06% of the portfolio and ranks #391 among its holdings. This is a return to the name: Steven Cohen previously reported a position in URGN as recently as Q2 2025.

Steven Cohen first reported a position in URGN in Q3 2018 and has held it in 15 quarters since. 188 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

  • Steven Cohen held 1,525,549 shares of UroGen Pharma worth $56.1M as of Q2 2026.
  • UroGen Pharma was a new Steven Cohen position in Q2 2026.
  • UroGen Pharma made up 0.06% of Steven Cohen's portfolio in Q2 2026, its #391 holding.
  • Steven Cohen first reported a position in UroGen Pharma in Q3 2018 and has held it in 15 quarters since.
  • 188 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.